The anti-CDK4/6 treatment against Cyclin Dependent Kinases 4/6 (CDK4/6) (commonly in combination with an endocrine therapy) is nowadays a mainstay for the treatment of this BC subtype. The gene discussed is CDK4; the disease is breast cancer.